These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 25170105)

  • 21. Comparing high-throughput methods to measure NK cell-mediated antibody dependent cellular cytotoxicity during HIV-infection.
    Konstantinus IN; Gamieldien H; Mkhize NN; Kriek JM; Passmore JA
    J Immunol Methods; 2016 Jul; 434():46-52. PubMed ID: 27094485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical Tenofovir Pre-exposure Prophylaxis and Mucosal HIV-Specific Fc-Mediated Antibody Activities in Women.
    Fisher KL; Mabuka JM; Sivro A; Ngcapu S; Passmore JS; Osman F; Ndlovu B; Abdool Karim Q; Abdool Karim SS; Chung AW; Baxter C; Archary D
    Front Immunol; 2020; 11():1274. PubMed ID: 32733445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural killer cytotoxicity and antibody-dependent cellular cytotoxicity of human immunodeficiency virus-infected cells by leukocytes from human neonates and adults.
    Jenkins M; Mills J; Kohl S
    Pediatr Res; 1993 May; 33(5):469-74. PubMed ID: 8511019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy.
    Tsai A; Irrinki A; Kaur J; Cihlar T; Kukolj G; Sloan DD; Murry JP
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28179531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody-Dependent Cellular Cytotoxicity Activity of Effector Cells from HIV-Infected Elite and Viral Controllers.
    Isitman G; Lisovsky I; Tremblay-McLean A; Kovacs C; Harris M; Routy JP; Bruneau J; Wainberg MA; Tremblay C; Bernard NF
    AIDS Res Hum Retroviruses; 2016; 32(10-11):1079-1088. PubMed ID: 27499379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reconstitution of NK cell activity in HIV-1 infected individuals receiving antiretroviral therapy.
    Weber K; Meyer D; Grosse V; Stoll M; Schmidt RE; Heiken H
    Immunobiology; 2000 Aug; 202(2):172-8. PubMed ID: 10993291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of NK cells by ADCC responses during early HIV infection.
    Chung AW; Navis M; Isitman G; Centre R; Finlayson R; Bloch M; Gelgor L; Kelleher A; Kent SJ; Stratov I
    Viral Immunol; 2011 Apr; 24(2):171-5. PubMed ID: 21449728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FcγRIII (CD16)-mediated ADCC by NK cells is regulated by monocytes and FcγRII (CD32).
    Bhatnagar N; Ahmad F; Hong HS; Eberhard J; Lu IN; Ballmaier M; Schmidt RE; Jacobs R; Meyer-Olson D
    Eur J Immunol; 2014 Nov; 44(11):3368-79. PubMed ID: 25100508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum and effector-cell antibody-dependent cellular cytotoxicity (ADCC) activity remains high during human immunodeficiency virus (HIV) disease progression.
    Ojo-Amaize E; Nishanian PG; Heitjan DF; Rezai A; Esmail I; Korns E; Detels R; Fahey J; Giorgi JV
    J Clin Immunol; 1989 Nov; 9(6):454-61. PubMed ID: 2576558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired natural killer cell-induced antibody-dependent cell-mediated cytotoxicity is associated with human immunodeficiency virus-1 disease progression.
    Jia M; Li D; He X; Zhao Y; Peng H; Ma P; Hong K; Liang H; Shao Y
    Clin Exp Immunol; 2013 Jan; 171(1):107-16. PubMed ID: 23199330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody-Dependent Cellular Cytotoxicity against Reactivated HIV-1-Infected Cells.
    Lee WS; Richard J; Lichtfuss M; Smith AB; Park J; Courter JR; Melillo BN; Sodroski JG; Kaufmann DE; Finzi A; Parsons MS; Kent SJ
    J Virol; 2016 Feb; 90(4):2021-30. PubMed ID: 26656700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brief Report: The Anti-HIV-1 ADCC-Mediating Antibodies From Cervicovaginal Secretions of HIV-Infected Women Have an Ability to Mediate Lysing of Autologous CD4+ HIV-Infected Cells.
    Dhande J; Angadi M; Murugavel KG; Poongulali S; Nandagopal P; Vignesh R; Ghate M; Kulkarni S; Thakar M
    J Acquir Immune Defic Syndr; 2018 Oct; 79(2):277-282. PubMed ID: 30211779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Viral control in chronic HIV-1 subtype C infection is associated with enrichment of p24 IgG1 with Fc effector activity.
    Chung AW; Mabuka JM; Ndlovu B; Licht A; Robinson H; Ramlakhan Y; Ghebremichael M; Reddy T; Goulder PJR; Walker BD; Ndung'u T; Alter G
    AIDS; 2018 Jun; 32(10):1207-1217. PubMed ID: 29620716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pol as a target for antibody dependent cellular cytotoxicity responses in HIV-1 infection.
    Isitman G; Chung AW; Navis M; Kent SJ; Stratov I
    Virology; 2011 Mar; 412(1):110-6. PubMed ID: 21269655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-HIV-1 ADCC Antibodies following Latency Reversal and Treatment Interruption.
    Lee WS; Kristensen AB; Rasmussen TA; Tolstrup M; Østergaard L; Søgaard OS; Wines BD; Hogarth PM; Reynaldi A; Davenport MP; Emery S; Amin J; Cooper DA; Kan VL; Fox J; Gruell H; Parsons MS; Kent SJ
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28539449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody-dependent cellular cytotoxicity against HIV-coated target cells by peripheral blood monocytes from HIV seropositive asymptomatic patients.
    Jewett A; Giorgi JV; Bonavida B
    J Immunol; 1990 Dec; 145(12):4065-71. PubMed ID: 2258607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short communication: Anti-HIV-1 envelope immunoglobulin Gs in blood and cervicovaginal samples of Beninese commercial sex workers.
    Batraville LA; Richard J; Veillette M; Labbé AC; Alary M; Guédou F; Kaufmann DE; Poudrier J; Finzi A; Roger M
    AIDS Res Hum Retroviruses; 2014 Nov; 30(11):1145-9. PubMed ID: 25354025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts.
    Hocqueloux L; Avettand-Fènoël V; Jacquot S; Prazuck T; Legac E; Mélard A; Niang M; Mille C; Le Moal G; Viard JP; Rouzioux C;
    J Antimicrob Chemother; 2013 May; 68(5):1169-78. PubMed ID: 23335199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NKG2D Acts as a Co-Receptor for Natural Killer Cell-Mediated Anti-HIV-1 Antibody-Dependent Cellular Cytotoxicity.
    Parsons MS; Richard J; Lee WS; Vanderven H; Grant MD; Finzi A; Kent SJ
    AIDS Res Hum Retroviruses; 2016; 32(10-11):1089-1096. PubMed ID: 27487965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathological Role of Anti-CD4 Antibodies in HIV-Infected Immunologic Nonresponders Receiving Virus-Suppressive Antiretroviral Therapy.
    Luo Z; Li Z; Martin L; Wan Z; Meissner EG; Espinosa E; Wu H; Yu X; Fu P; Julia Westerink MA; Kilby JM; Wu J; Huang L; Heath SL; Li Z; Jiang W
    J Infect Dis; 2017 Jul; 216(1):82-91. PubMed ID: 28498953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.